Company marks second consecutive year as top pharmaceutical employer
MISSISSAUGA, ON, Jan. 7 /CNW/ - GlaxoSmithKline Inc. (GSK) has once again
been named one of the 50 Best Employers in Canada in the annual list published
by The Globe and Mail's Report on Business Magazine.
"As the country's largest bio-pharmaceutical employer, we are very proud
that our employees have once again recognized us as a top ten employer and as
the top pharmaceutical employer in Canada," said Paul Lucas, President and
CEO, GlaxoSmithKline Inc. "Our employees are our greatest asset, and their
continued commitment and engagement is what enables us to offer life-changing
medicines and vaccines to Canadians and people around the world."
"The Best Employers in Canada survey tells us that our employees are
particularly motivated by the significant impact of our work on the lives of
our friends, family and neighbors," added Mr. Lucas. The 2008 survey marks the
seventh consecutive year on the list for the research-based pharmaceutical
GSK is the country's largest bio-pharmaceutical contributor to Canadian
research and development, investing more than $176 million in 2006 alone, and
is Canada's leading flu vaccine manufacturer, supplying 75 per cent of
Canadian government seasonal flu vaccine purchases.
The company recently announced the completion of a two year, $199 million
investment to upgrade and expand its Quebec City influenza vaccine
manufacturing facility, and has doubled the size of its vaccine workforce in
Quebec City since January 2006.
In the survey, employees identified their physical work environment and
their co-workers are key factors that make GlaxoSmithKline a great place to
work. The survey also highlighted the company's people practices as a key
driver for employee engagement.
GlaxoSmithKline is committed to challenging, developing, rewarding and
recognizing its employees. The company offers flexible work hours and a
compressed work week (self-managed time), compassionate and adoptive parent
leave, and competitive pregnancy/parental leave. The company also offers a
wide range of on-site services, including fitness facilities and nutritious
meals in subsidized cafeterias.
GlaxoSmithKline is designated a Caring Company by Imagine Canada, a
national organization that supports Canada's charities, non-profit
organizations and community-minded businesses. The company annually donates a
minimum of one per cent pre-tax profits through The GlaxoSmithKline Foundation
and other channels.
GlaxoSmithKline is also a leading contributor to Health Partners
International of Canada (HPIC), a charitable organization that provides
medications, medical supplies and vaccines, donated by Canada's research-based
pharmaceutical companies, to developing world countries and disaster areas.
Since 1994, GlaxoSmithKline has contributed $22 million in humanitarian
GlaxoSmithKline - one of the world's leading research-based
pharmaceutical and health-care companies - is committed to improving the
quality of life by enabling people to do more, feel better and live longer. In
Canada, GlaxoSmithKline is among the top 15 investors in Canadian research and
development, and invested more than $176 million in 2006 alone.
For further information:
For further information: Peter Schram, GlaxoSmithKline Inc., (905)